Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
A Non-Invasive Solution to a Confident Neckline: Botox for Platysmal Bands
Via 24-7 Press Release
Exposures Product Safety
Insmed Stock Closes At Nearly 25-Year High As Analysts Get Bullish On FDA Nod For Lung Disease Drug: Retail Traders Ecstatic
Via Stocktwits
Tickers BAC INSM RY TSX:RY WFC
Exposures Product Safety
Vicarious Surgical Narrows Loss in Q2
Via The Motley Fool
Topics Intellectual Property
Tickers RBOT
Exposures Intellectual Property Product Safety
NeuroPace (NPCE) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Tickers NPCE
Exposures Financial Product Safety
NeuroPace Reports Record Q2 Revenue
Via The Motley Fool
Tickers NPCE
Exposures Product Safety
Insmed Announces FDA Approval For Drug To Treat Chronic Lung Disease
Via Stocktwits
Tickers INSM
Exposures Product Safety
Cue Biopharma Inc (NASDAQ:CUE) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected
Via Chartmill
Tickers CUE
Exposures Product Safety
ProKidney Corp (NASDAQ:PROK) Reports Mixed Q2 2025 Results with Regulatory Progress and Narrower Loss
Via Chartmill
Tickers PROK
Exposures Product Safety
SPECTRAL AI INC (NASDAQ:MDAI) Q2 2025 Earnings: Revenue Misses, Losses Widen Amid Regulatory Progress
Via Chartmill
Topics Artificial Intelligence
Tickers MDAI
Exposures Artificial Intelligence Product Safety
Levi & Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Replimune Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Replimune Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside
Via MarketBeat
Topics Death
Tickers SLDB SRPT WFC
Exposures Death Product Safety
FDA Approves Insmed's Drug As First Treatment For Type Of Chronic Lung Disease
Via Benzinga
Tickers INSM
Exposures Product Safety
Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
Via Benzinga
Tickers AMPH FMS VTRS
Exposures Product Safety
Top 5% Biotech, Insmed, Hits A Record High On Its 'Skeleton Key' Approval
Via Investor's Business Daily
Tickers INSM LLY
Exposures Product Safety
Hims & Hers Remains Outside Novo Nordisk's Growing Legal Storm For Now
Via Benzinga
Topics Lawsuit
Tickers HIMS LLY NVO
Exposures Financial Legal Product Safety
Never settle: How Jimmy's story with GPP inspires greater action and support
Via Brandpoint
Topics Product Recall
Exposures Legal Product Safety
Tonix Pharmaceuticals (TNXP) Stock Surges On Q2 Earnings Beat And Upcoming FDA Catalyst
Via Benzinga
Topics Earnings
Tickers TNXP
Exposures Financial Product Safety
Pfizer In Spotlight As FDA Reportedly Mulls Withdrawing Authorization For COVID-19 Vaccine For Kids Under 5: Retail Says Stock Is Undervalued
Via Stocktwits
Tickers MRNA PFE TSLA
Exposures COVID-19 Product Safety
Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
Via FinancialNewsMedia
Topics Artificial Intelligence
Tickers AVAI BTAI PFE RLYB RXRX
Exposures Artificial Intelligence Product Safety
Ford Issues A Recall For 103,000 F-150 Pickup Trucks Over Damaged Axle Bolt
Via Benzinga
Topics Product Recall
Tickers F
Exposures Legal Product Safety
Retail Turns Bearish On Bayer After $1.3B Kumquat Cancer Drug Deal
Via Stocktwits
Tickers BAYRY
Exposures Product Safety
AMPH Q2 Deep Dive: BAQSIMI Momentum, Margin Pressures, and Pipeline Milestones
Via StockStory
Topics Economy
Tickers LLY
Exposures Product Safety Supply Chain
Avis Budget Group’s Q2 Earnings Call: Our Top 5 Analyst Questions
Via StockStory
Topics Earnings Product Recall World Trade
Exposures Financial Legal Product Safety
CAR Q2 Deep Dive: Avis Launches Premium Offering and Expands Autonomous Fleet Partnerships
Via StockStory
Topics Product Recall World Trade
Tickers CAR
Exposures Legal Product Safety Tariff
Why Small-Cap Biotech NRx Pharmaceuticals Is Drawing Heavy Retail Buzz
Via Stocktwits
Tickers NRXP
Exposures Product Safety
$3 Billion Suicidal Depression Market May Soon be Accessible via FDA Fast Track Designation for Effective NRX 100 Drug Therapy: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Tickers NRXP
Exposures Product Safety
This Stock Has Tumbled 50% In One Year, Gets A Price Target Cut Today – But Retail Believes $400-450 Is A Good Entry Point
Via Stocktwits
Tickers AVUS DWSH NVS REGN
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.